Evidence method
Level · gp.fundamentals.debt_to_revenue
12.32% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Dec 31, 2017
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-18-000006General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.18% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.47% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
5.96% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
13.46% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
32.06% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
14.31% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.45% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.01% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 8.61%
- Current
- 8.18%
- Delta
- -0.43%
- Previous
- 19.04%
- Current
- 16.47%
- Delta
- -2.57%
- Previous
- 5.71%
- Current
- 5.96%
- Delta
- 0.26%
- Previous
- 54.19%
- Current
- 13.46%
- Delta
- -40.74%
- Previous
- 31.39%
- Current
- 32.06%
- Delta
- 0.66%
- Previous
- 16.05%
- Current
- 14.31%
- Delta
- -1.73%
- Previous
- 2.29%
- Current
- 2.45%
- Delta
- 0.16%
- Previous
- 1.16%
- Current
- 1.01%
- Delta
- -0.15%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_DECREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_DECREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.